NRCT-101SR

· Neurocentria, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NRCT-101SR, covering 2025-04-27 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD [Phase 2, Phase 3]